IVF For Difficult Cases: How To Choose The Right Clinic When Standard Protocols Do Not Apply
Written by Dr. Archana Agarwal — IVF Specialist in Bangalore, Founder & Medical Director, Mannat Fertility Clinic
Most IVF information is written for the patient with an average prognosis. It walks through what a standard stimulation cycle looks like, what the typical success rates are, how many cycles to expect. Useful enough - but it leaves a real gap for the patients who do not fit the average picture: women with very low ovarian reserve, women who have already had failed cycles somewhere else, patients with recurrent implantation failure, or those carrying endometriosis, a uterine anomaly, or a significant male-factor alongside their own fertility challenges.
Who Counts as a "Difficult Case"
The clinical term you will hear most is "poor ovarian responder," POR - a patient who produces fewer eggs than expected during controlled ovarian stimulation. A PMC review on poor responders in IVF notes that they make up more than a third of women going through assisted reproduction - a far larger share than the phrase "difficult case" would ever suggest.
Beyond the low response, there are other situations that call for more individualised management: recurrent implantation failure, meaning two or more failed embryo transfers with good-quality embryos; repeated early pregnancy loss; patients with very high AMH who risk hyperstimulation on standard doses; and patients who simply did not respond to a previous clinic's chosen protocol.
What Good Individualised Management Looks Like
For poor responders specifically, the evidence backs a few concrete strategies. Protocol adjustment is where it starts - switching between GnRH agonist and antagonist protocols, changing the gonadotropin type and dose, and in some cases folding in adjuncts like growth hormone or testosterone priming to improve follicle sensitivity.
The POSEIDON criteria - a classification system that sorts poor-prognosis patients into four sub-types by age, AMH or AFC, and previous cycle performance - give you a framework for tailoring the approach rather than applying one blanket poor-responder protocol to everybody.
Accumulation strategies are another route: banking oocytes or embryos across several lower-yield cycles before you proceed to a transfer, rather than transferring the one or two embryos from a single poor response. This takes a lab with strong vitrification protocols, and the clinical discipline to recommend it even when the patient is eager to transfer right now.
PGT-A, preimplantation genetic testing for aneuploidy, becomes increasingly relevant in older patients or in those with recurrent implantation failure - selecting the chromosomally normal embryos cuts the chance of a failed transfer and an early loss, though it also shrinks the pool of available embryos and brings its own costs and considerations along with it.
What to Ask a Clinic When Your Case Is Complex
Ask directly. How many poor responders have they treated, and what is their approach to choosing a stimulation protocol? Do they use POSEIDON, or an equivalent classification? Is PGT-A available in-house or outsourced, and how do they counsel patients on when it actually adds value? What is their policy on cancelled cycles - will they go ahead to retrieval with a low follicle count, or cancel and replan?
A clinic that offers only one or two protocols and has not run into many low-responders is not wrong - it may just not be the right fit for a patient who needs protocol flexibility. At Mannat Fertility Clinic, Dr Archana Aggarwal have treated patients who came to us after failed cycles elsewhere, run on protocols that were never calibrated to their specific reserve profile. A full review of the previous cycle reports - the medication doses, the peak estradiol, the number of follicles, the number of eggs retrieved - is where the next cycle's strategy actually begins.
This article is for general information only and is not a substitute for individualised medical advice. Patients with complex fertility histories should seek specialist evaluation before assuming their prognosis from previous cycle outcomes.
Frequently Asked Questions
1. What makes someone a poor responder in IVF?
A poor ovarian responder is usually defined as someone who produces fewer eggs than expected during controlled stimulation - typically fewer than four oocytes retrieved on a maximal stimulation dose, or with abnormal ovarian reserve test results, an AMH below 0.5 to 1.1 ng/mL or an AFC below 5 to 7. The POSEIDON criteria sort poor responders into four sub-groups by age, reserve markers, and previous cycle history, which helps personalise the management rather than applying a single protocol to every low-responder.
2. Can I do IVF if I have low AMH?
Yes. A low AMH reduces the expected number of eggs per cycle, but it does not take IVF off the table. Management typically means a tailored stimulation protocol at higher doses, and in some cases adjuncts like growth hormone or testosterone priming. Cumulative strategies - freezing embryos across several cycles before a transfer - can be used when a single cycle yields only one or two embryos. A realistic success estimate drawn from your specific AMH and AFC, rather than some generalised figure, is the right basis for the decision.
3. What is recurrent implantation failure?
Recurrent implantation failure, RIF, is generally defined as two or more failed embryo transfers despite good-quality embryos. It is distinct from poor ovarian response - the problem here is not the egg retrieval, it is the embryo not implanting. The contributing factors can include uterine cavity abnormalities, endometrial receptivity issues, thrombophilia, immune factors, and embryo chromosomal abnormalities that were never screened for. Evaluation after RIF typically takes in hysteroscopy, an endometrial receptivity assessment, and a review of embryo quality and PGT-A candidacy.
